BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 15/03/2000

FDA Announces Pilot Program for Licensing Gamma Irradiated Blood and Blood Components

The FDA has released a guidance document and established a pilot program to allow licensed blood product manufacturers to market irradiated blood components in interstate commerce, streamlining the licensing process while maintaining product safety and purity.

Source: Federal Register — Food and Drug AdministrationOpen original release →